Sökning: onr:"swepub:oai:DiVA.org:liu-174120" >
Therapeutics target...
-
Ghoreschi, KamranCharite Univ Med Berlin, Germany
(författare)
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
- Artikel/kapitelEngelska2021
Förlag, utgivningsår, omfång ...
-
ELSEVIER SCIENCE INC,2021
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-174120
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-174120URI
-
https://doi.org/10.1016/S0140-6736(21)00184-7DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:for swepub-publicationtype
Anmärkningar
-
Psoriasis is a chronic inflammatory disease characterised by sharply demarcated erythematous and scaly skin lesions accompanied by systemic manifestations. Classified by WHO as one of the most serious non-infectious diseases, psoriasis affects 2-3% of the global population. Mechanistically, psoriatic lesions result from hyperproliferation and disturbed differentiation of epidermal keratinocytes that are provoked by immune mediators of the IL-23 and IL-17 pathway. Translational immunology has had impressive success in understanding and controlling psoriasis. Psoriasis is the first disease to have been successfully treated with therapeutics that directly block the action of the cytokines of this pathway; in fact, therapeutics that specifically target IL-23, IL-17, and IL-17RA are approved for clinical use and show excellent efficacy. Furthermore, inhibitors of IL-23 and IL-17 intracellular signalling, such as TYK2 or ROR gamma t, are in clinical development. Although therapies that target the IL-23 and IL-17 pathway also improve psoriatic arthritis symptoms, their effects on long-term disease modification and psoriasis-associated comorbidities still need to be explored.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Balato, AnnaUniv Naples Federico II, Italy
(författare)
-
Enerbäck, CharlottaLinköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten,Region Östergötland, Hudkliniken i Östergötland(Swepub:liu)chaen00
(författare)
-
Sabat, RobertCharite Univ Med Berlin, Germany
(författare)
-
Charite Univ Med Berlin, GermanyUniv Naples Federico II, Italy
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:The Lancet: ELSEVIER SCIENCE INC397:10275, s. 754-7660140-67361474-547X
Internetlänk
Hitta via bibliotek
Till lärosätets databas